Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shinva Medical Instrument CoSHSE:600587 +2.04%66 Debt-to-EBITDA is 1.83 as of Mar. 2026, which is 7% above its 10-year median of 1.71. GuruFocus rates SHSE:600587 with a GF Score™ of 66/100 and a GF Value™ of ¥15.86 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 474 Medical Devices & Instruments companies, Shinva Medical Instrument Co ranks worse than 59.07% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Shinva Medical Instrument Co's Debt-to-EBITDA or its related term are showing as below:
SHSE:600587'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.08 Med: 1.71 Max: 6.65
Current: 1.97
During the past 13 years, the highest Debt-to-EBITDA Ratio of Shinva Medical Instrument Co was 6.65. The lowest was 1.08. And the median was 1.71.
SHSE:600587's Debt-to-EBITDA is ranked worse than 59.07% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 1.595
vs SHSE:600587: 1.97
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Shinva Medical Instrument Co Debt-to-EBITDA Related Terms
Shinva Medical Instrument Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600587 vs ABT, SYK, MDT: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Shinva Medical Instrument Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shinva Medical Instrument Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shinva Medical Instrument Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shinva Medical Instrument Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Shinva Medical Instrument Co (SHSE:600587) has a Debt-to-EBITDA of 1.83 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Shinva Medical Instrument Co. This is near median its historical median of 1.71. Over the past decade, Shinva Medical Instrument Co's Debt-to-EBITDA has ranged from 1.08 to 6.65. According to the industry distribution chart, Shinva Medical Instrument Co ranks #280 out of 474 companies in the Medical Devices & Instruments industry, placing it in the top 59.1%.
Is Shinva Medical Instrument Co's Debt-to-EBITDA too high?
Shinva Medical Instrument Co's current Debt-to-EBITDA of 1.83 is near median its 10-year median of 1.71. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 6.65. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.60. Shinva Medical Instrument Co's value of 1.83 is 14.7% above this industry median. Based on the distribution chart, Shinva Medical Instrument Co ranks #280 out of 474 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shinva Medical Instrument Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shinva Medical Instrument Co's Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shinva Medical Instrument Co ranks #280 out of 474 companies for Debt-to-EBITDA. This places Shinva Medical Instrument Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.60. Shinva Medical Instrument Co's value of 1.83 is 14.7% above this benchmark. Historically, Shinva Medical Instrument Co's own Debt-to-EBITDA has ranged from 1.08 to 6.65 over the past decade. While the company's 10-year median is 1.71 vs. the industry median of 1.60, Shinva Medical Instrument Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.60, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shinva Medical Instrument Co's current Debt-to-EBITDA of 1.83 is 14.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Shinva Medical Instrument Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shinva Medical Instrument Co's current Debt-to-EBITDA is 1.83, which is near median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shinva Medical Instrument Co stock overvalued right now?
Based on GuruFocus' analysis, Shinva Medical Instrument Co (SHSE:600587) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.86, compared to a current price of ¥12.48 — trading 21.3% below its estimated fair value. The current Debt-to-EBITDA is 1.83, which is near median its 10-year median of 1.71 and 14.7% above the Medical Devices & Instruments industry median of 1.60. Shinva Medical Instrument Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Shinva Medical Instrument Co (SHSE:600587), the current Debt-to-EBITDA is 1.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shinva Medical Instrument Co (SHSE:600587) Overvalued in 2026?
Based on GuruFocus' analysis, Shinva Medical Instrument Co stock appears to be undervalued.
The current stock price of ¥12.48 is trading 21.3% below its estimated GF Value™ of ¥15.86.
GuruFocus considers Shinva Medical Instrument Co to be Modestly Undervalued.
Key valuation signals for SHSE:600587:
Debt-to-EBITDA: 1.83 (near median its 10-year median of 1.71)
GF Value™: ¥15.86 vs. price of ¥12.48 (21.3% below fair value)
Industry Position: 14.7% above the Medical Devices & Instruments median (#280 of 474)
No single metric tells the full story. See the SHSE:600587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shinva Medical Instrument Co Ltd manufactures medical instruments in China. Its main products include sterilizers and testing products, radiotherapy and digital diagnosis equipment, surgical instruments and pharmaceutical machinery.
66GF Score
Get the complete analysis for SHSE:600587
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600587 has been successfully added to your 
